Success Metrics

Clinical Success Rate
94.7%

Based on 18 completed trials

Completion Rate
95%(18/19)
Active Trials
1(3%)
Results Posted
6%(1 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_3
2
7%
Ph not_applicable
9
30%
Ph phase_2
2
7%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
2(15.4%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

94.7%

18 of 19 finished

Non-Completion Rate

5.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

30

all time

Status Distribution
Active(1)
Completed(18)
Terminated(1)
Other(10)

Detailed Status

Completed18
unknown10
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
30
Active
1
Success Rate
94.7%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (15.4%)
Phase 32 (15.4%)
N/A9 (69.2%)

Trials by Status

completed1860%
terminated13%
recruiting13%
unknown1033%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT03844750Phase 2

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Terminated
NCT06559761

Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research

Recruiting
NCT06329700

Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy

Completed
NCT05771025Not Applicable

Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases

Unknown
NCT05471674Phase 2

Neoadjuvant Anti-PD1 in HCC

Completed
NCT05450874

A Novel MSE Score to Predict rHCC Patients

Completed
NCT05402644

Hepatectomy for Early-stage HCC Patients With CSPH

Completed
NCT05273489

Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.

Completed
NCT04163887Not Applicable

Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases

Unknown
NCT04748081

The Major Bleeding Risk Following Hepatectomy

Completed
NCT04705194

Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging

Unknown
NCT04709718

Surgical Management of Giant Hepatic Hemangioma

Completed
NCT04299919

The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment

Unknown
NCT04072250

Surgery for Recurrent Intrahepatic Cholangiocarcinoma

Completed
NCT03888638

The Role of Tumor-associated Macrophages in Colorectal Liver Metastases

Completed
NCT03614546Not Applicable

Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma

Unknown
NCT03430635

Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma

Completed
NCT03178409

Combined HCC-MFCCC

Completed
NCT03171428

Hepatectomy With or Without the Thoraco-abdominal Approach

Completed
NCT02523053Not Applicable

Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
30